These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38436919)

  • 1. Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes.
    Kral J; Benes M; Lanska V; Macinga P; Drastich P; Spicak J; Hucl T
    Obes Surg; 2024 May; 34(5):1407-1414. PubMed ID: 38436919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
    Glaysher MA; Mohanaruban A; Prechtl CG; Goldstone AP; Miras AD; Lord J; Chhina N; Falaschetti E; Johnson NA; Al-Najim W; Smith C; Li JV; Patel M; Ahmed AR; Moore M; Poulter N; Bloom S; Darzi A; Le Roux C; Byrne JP; Teare JP
    BMJ Open; 2017 Nov; 7(11):e018598. PubMed ID: 29146657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
    Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
    Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients.
    Forner PM; Ramacciotti T; Farey JE; Lord RV
    Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).
    Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
    Obes Surg; 2018 Aug; 28(8):2187-2196. PubMed ID: 29504053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion.
    Lee WJ; Almulaifi AM; Tsou JJ; Ser KH; Lee YC; Chen SC
    Surg Obes Relat Dis; 2015; 11(4):765-70. PubMed ID: 25813754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Type 2 Diabetes Mellitus.
    Seki Y; Kasama K; Umezawa A; Kurokawa Y
    Obes Surg; 2016 Sep; 26(9):2035-2044. PubMed ID: 26749411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
    Balint IB; Csaszar F; Somodi K; Ternyik L; Biro A; Kaposztas Z
    Langenbecks Arch Surg; 2021 Aug; 406(5):1363-1377. PubMed ID: 33712874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
    Günthert SJ; Aksan A; Schröder O; Meyer G; Hausmann J; Stein J; Stier C
    Surg Endosc; 2022 Aug; 36(8):5979-5985. PubMed ID: 35378626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.
    Naitoh T; Kasama K; Seki Y; Ohta M; Oshiro T; Sasaki A; Miyazaki Y; Yamaguchi T; Hayashi H; Imoto H; Tanaka N; Unno M
    Obes Surg; 2018 Feb; 28(2):497-505. PubMed ID: 28795271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.
    Seki Y; Kasama K; Haruta H; Watanabe A; Yokoyama R; Porciuncula JP; Umezawa A; Kurokawa Y
    Obes Surg; 2017 Mar; 27(3):795-801. PubMed ID: 27644433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Early Reimplantation of the Duodenal-Jejunal Bypass Liner Viable?
    Leventi E; Günthert SJ; Stier C; Staikov P; Stein J; Farrag K
    Obes Surg; 2019 May; 29(5):1690-1693. PubMed ID: 30826914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
    Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Japanese Patients with BMI < 35 kg/m
    Seki Y; Kasama K; Yasuda K; Yokoyama R; Porciuncula JP; Kurokawa Y
    Obes Surg; 2018 Aug; 28(8):2429-2438. PubMed ID: 29502278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
    Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
    Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisional One Anastomosis Gastric Bypass (OAGB) for Poor Response of Duodenal-Jejunal Bypass with Sleeve Gastrectomy (DJB-SG) (Video Report).
    Liu FG; Chang SW; Hsu KF; Chen YJ; Pan HM; Liao GS; Lin CH; Wang SC
    Obes Surg; 2023 May; 33(5):1616-1619. PubMed ID: 36856990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery.
    Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW
    Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Patel N; Mohanaruban A; Ashrafian H; Le Roux C; Byrne J; Mason J; Hopkins J; Kelly J; Teare J
    Obes Surg; 2018 Jul; 28(7):1980-1989. PubMed ID: 29450844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roux-en Y gastric bypass is superior to duodeno-jejunal bypass in improving glycaemic control in Zucker diabetic fatty rats.
    Seyfried F; Bueter M; Spliethoff K; Miras AD; Abegg K; Lutz TA; le Roux CW
    Obes Surg; 2014 Nov; 24(11):1888-95. PubMed ID: 24927690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.